ArticlePloS one2025
Unveiling the mechanism of dodecylphosphorylcholine as an extremely promising drug delivery system: From self-assembly clusters to drug encapsulation pathways.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significant progress has been achieved in cancer treatment with Doxorubicin (DOX), yet its low toxicity and poor bioavailability have long troubled scientists. Dodecylphosphorylcholine (DPC), as a candidate material for drug delivery systems (DDS), holds promise in assisting DOX to overcome its application bottleneck. In this study, employing a combination of quantum chemical calculations and molecular simulations, we delve into the dynamic processes of the interaction between DPC and DOX molecules for the first time. The results indicate that, under the synergistic effect where electrostatic repulsion plays a minor role and van der Waals attraction predominates, the end (containing choline group) of DPC molecules aggregate, self-assembling into multiple molecular clusters. There is a notable presence of electrostatic attraction and van der Waals attraction between DPC and DOX, which drives the adsorption or encapsulation of DOX molecules by DPC molecular clusters, thus presenting a favorable drug-loading conformation. During these processes, a substantial number of DPC molecules aggregate around DOX, with typical distances for interaction around 0.5 nm. The shape and position of DPC-DOX molecular clusters undergo significant dynamic changes within a simulated time of 0-70 ns, stabilizing thereafter. Our findings elucidate the interaction mechanism between DPC and DOX at the molecular scale, paving new avenues for the experimental synthesis of promising DDS eagerly sought by DOX.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.